Article Details
Retrieved on: 2021-01-25 18:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Status: RedHill Biopharma said November 17 that the FDA has cleared the Company's IND application for a Phase II/III trial evaluating RHB-107 in ...
Article found on: www.genengnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here